Article Details

Philip Morris CEO defends the company's intentions to buy inhaler maker Vectura

Retrieved on: 2021-07-21 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Philip Morris CEO defends the company's intentions to buy inhaler maker Vectura. View article details on hiswai:

Excerpt

Revenue of $7.59 billion fell short of a Refinitiv forecast of $7.69 billion. Still, the stock is up nearly 15% year to date. Olczak said he believes it was a ...

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up